Article
New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere.
Expert opinion on therapeutic targets - 1 Jan 2000
Bruchim Ilan, Capasso Ilaria, Polonsky Ariel, Meisel Shilhav, Salutari Vanda, Werner Haim, Lorusso Domenica, Scambia Giovanni, Fanfani Francesco
Abstract excerpt
INTRODUCTION: Endometrial cancer (EC) is the only gynecologic malignancy showing increasing trends in incidence and mortality. While standard treatment has been effective primarily for early-stage EC, precision medicine with tailored therapy has revolutionized the management of this disease. Genome sequencing analyses have identified four sub-types of EC. Treatments for primary and metastatic disease can now be...
Topics
- Humans
- Female
- Mutation
- Endometrial Neoplasms
- Prognosis
